Lv5
1060 积分 2024-12-09 加入
Targeting STAT3 Pathway: A Promising Immunotherapeutic Strategy for Triple-Negative Breast Cancer – Current Status and Future Outlooks
1个月前
已完结
Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy
4个月前
已完结
Influence of polyethylene glycol coating of different molecular weights and densities on liposome properties
5个月前
已完结
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
5个月前
已完结
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
5个月前
已关闭
PD-1/PD-L1 inhibitors combined with anti-angiogenic drugs for advanced triple-negative breast cancer: synergistic mechanisms and research progress
5个月前
已完结
Potential roles and molecular mechanisms of phytochemicals against cancer
5个月前
已完结
The Inhibitory Effects of Ganoderma lucium on Cell Proliferation, Apoptosis, and TNF‐α‐Induced CCL2 Release in Genetically Different Triple‐Negative Breast Cancer Cells
6个月前
已关闭
Immune cellular components and signaling pathways in the tumor microenvironment
6个月前
已完结
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer
6个月前
已完结
皖公网安备34019202002308
